DKK1 Positively Correlates with Lung Function in COPD Patients and Reduces Airway Inflammation.

DKK1 levels were decreased in COPD patients and positively correlated with lung function, overexpression of DKK1 and andrographolide attenuated airway cell inflammation, both suggesting a potential role in pathophysiology and providing a disease-specific biomarker pattern.